442 related articles for article (PubMed ID: 15525615)
1. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
[TBL] [Abstract][Full Text] [Related]
2. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
Craft RM; Lee DA
Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
[TBL] [Abstract][Full Text] [Related]
3. Dextromethorphan differentially affects opioid antinociception in rats.
Chen SL; Huang EY; Chow LH; Tao PL
Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
[TBL] [Abstract][Full Text] [Related]
4. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
[TBL] [Abstract][Full Text] [Related]
5. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
6. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
[TBL] [Abstract][Full Text] [Related]
7. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
8. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
10. N-Methyl-D-aspartate receptor antagonist d-AP5 prevents pertussis toxin-induced alterations in rat spinal cords by inhibiting increase in concentrations of spinal CSF excitatory amino acids and downregulation of glutamate transporters.
Wong CS; Wu GJ; Chen WF; Jean YH; Hung CH; Lin CS; Huang SY; Wen ZH
Brain Res Bull; 2009 Aug; 80(1-2):69-74. PubMed ID: 19463918
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
[TBL] [Abstract][Full Text] [Related]
12. Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats.
Luger TJ; Lorenz IH; Grabner-Weiss C; Hayashi T
Br J Pharmacol; 1995 Mar; 114(5):1097-103. PubMed ID: 7780645
[TBL] [Abstract][Full Text] [Related]
13. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat.
Grass S; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
Acta Physiol Scand; 1996 Nov; 158(3):269-73. PubMed ID: 8931770
[TBL] [Abstract][Full Text] [Related]
14. Dextromethorphan potentiates morphine-induced antinociception at both spinal and supraspinal sites but is not related to the descending serotoninergic or adrenergic pathways.
Chow LH; Huang EY; Ho ST; Tsai SK; Tao PL
J Biomed Sci; 2004; 11(6):717-25. PubMed ID: 15591767
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
17. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
Hao JX; Xu XJ
Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
[TBL] [Abstract][Full Text] [Related]
18. Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study.
Weinbroum AA; Gorodetzky A; Nirkin A; Kollender Y; Bickels J; Marouani N; Rudick V; Meller I
Cancer; 2002 Sep; 95(5):1164-70. PubMed ID: 12209704
[TBL] [Abstract][Full Text] [Related]
19. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive.
Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F
Neurosci Lett; 1995 Oct; 199(2):87-90. PubMed ID: 8584250
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
